The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer

被引：11

作者：

Bemis D.L. ^{[1
]}

Capodice J.L. ^{[1
]}

Costello J.E. ^{[1
]}

Vorys G.C. ^{[1
]}

Katz A.E. ^{[1
]}

Buttyan R. ^{[1
]}

机构：

[1] Department of Urology, Columbia University, Irving-II, New York, NY 10032

来源：

Current Urology Reports | 2006年 / 7卷 / 3期

关键词：

Prostate Cancer; Curcumin; Resveratrol; Prostate Cancer Cell; Genistein;

D O I：

10.1007/s11934-006-0017-x

中图分类号：

学科分类号：

摘要：

Having a high probability of experiencing prostate cancer during their lifetime, men are increasingly seeking protection against this disease with the use of over-the-counter dietary supplements containing herbs, vitamins, or plant-derived biochemical agents. The use of these agents for prostate cancer prevention is driven by epidemiology supporting the idea that regional diets and consumption of specific dietary components (certain herbs, vitamins, isoflavones, and polyphenols) are associated with a lower risk for prostate cancer, in conjunction with basic research that is defining molecules within food substances that kill or suppress growth of cultured human prostate cancer cells. Moreover, there is a sense that these dietary agents lack side effects, although this assumption often is faulty. Unfortunately, at this time, there is insufficient clinical evidence to support the widespread use of these dietary supplements for chemoprevention of prostate cancer, although ongoing clinical trials of the most promising vitamins and minerals are approaching conclusion. Copyright © 2006 by Current Science Inc.

引用

页码：166 / 174

页数：8

共 91 条

[51]

Dong Y., Zhang H., Hawthorn L., Ganther H.E., Ip C., Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array, Cancer Res, 63, pp. 52-59, (2003)

[52]

Corcoran N.M., Najdovska M., Costello A.J., Inorganic selenium retards progression of experimental hormone refractory prostate cancer, J Urol, 171, pp. 907-910, (2004)

[53]

Lee M.M., Gomez S.L., Chang J.S., Et al., Soy and isoflavone consumption in relation to prostate cancer risk in China, Cancer Epidemiol Biomarkers Prev, 12, pp. 665-668, (2003)

[54]

Holzbeierlein J.M., McIntosh J., Thrasher J.B., The role of soy phytoestrogens in prostate cancer, Curr Opin Urol, 15, pp. 17-22, (2005)

[55]

Sarkar F.H., Li Y., Soy isoflavones and cancer progression, Cancer Invest, 21, pp. 744-757, (2003)

[56]

Akiyama T., Ishida J., Nakagawa S., Et al., Genistein, a specific inhibitor of tyrosine-specific protein kinases, J Biol Chem, 262, pp. 5592-5595, (1987)

[57]

Constantinou A., Mehta R., Runyan C., Et al., Flavonoids as DNA topoisomerase antagonists and poisons: Structure-activity relationships, J Nat Prod, 58, pp. 217-225, (1995)

[58]

Fotsis T., Pepper M., Adlercreutz H., Et al., Genistein, a dietary-derived inhibitor of in vitro angiogenesis, Proc Natl Acad Sci USA, 90, pp. 2690-2694, (1993)

[59]

Shen J.C., Klein R.D., Wei Q., Et al., Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells, Mol Carcinog, 29, pp. 92-102, (2000)

[60]

Mentor-Marcel R., Lamartiniere C.A., Eltoum I.A., Et al., Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP), J Nutr, 135, pp. 989-995, (2005)

← 1 2 3 4 5 6 7 8 9 10 →